By Helena Smolak


Novo Holdings said it plans to invest $200.5 million in a quantum technology hub in Denmark, a move that aligns with the company's strategy to grow investment in this industry.

The controlling shareholder of Novo Nordisk--manufacturer of weight-loss drug Ozempic--said Wednesday that it aims to build an ecosystem of quantum computing start-ups applied to life sciences in the Nordics. Quantum computing refers to the use of specialized technology that solves complex problems that classical computers or supercomputers can't solve.

"Quantum technology is a disruptive and transformative field that can revolutionise various sectors and address global challenges," Soren Moller, managing partner of Novo Holdings' Life Science Investments Unit said.

The investment arm of the Novo Nordisk Foundation said its investment will potentially extend beyond the Nordics, it said.


Write to Helena Smolak at helena.smolak@wsj.com


(END) Dow Jones Newswires

05-01-24 0506ET